US2007238195A1PendingUtilityA1

Conformational and topological protein regulation

Assignee: UNIV CALIFORNIAPriority: Dec 15, 1999Filed: Mar 15, 2007Published: Oct 11, 2007
Est. expiryDec 15, 2019(expired)· nominal 20-yr term from priority
A61K 39/00C07K 14/47A01K 2267/0343C07K 2319/033G01N 33/5088C07K 2319/04A01K 67/0275G01N 33/5076C07K 2319/02G01N 33/6878G01N 33/5047G01N 33/6896C12N 15/625C07K 2319/75C12N 15/635C12N 15/8509G01N 33/68A01K 2227/105G01N 33/6842A01K 2217/05G01N 33/502G01N 33/6845C07K 2319/61G01N 33/5008A01K 2267/0356
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and compositions are provided for identifying novel conformers of proteins not known to exist as different conformers. By using chimeric genes replacing a native signal sequence with a different signal sequence resulting in the production of a conformer, one can compare the native protein with the product of the chimeric gene. Where the conformations are different, the different protein may be used for production of antibodies, elucidation of mechanisms associated with the native and different conformer protein, assays for the presence of the different conformer in physiological samples, identification of compounds specifically binding to the conformer, particularly drugs, etc. Where the formation of the conformer is associated with a diseased state, the conformer may be used in screens to identify compounds as drug candidates.

Claims

exact text as granted — not AI-modified
1 - 16 . (canceled)  
     
     
         17 . A method for identifying the presence of a conformer in a sample, said method comprising; 
 combining said sample with an antibody that binds to a wild-type protein; and    detecting the altered binding of said antibody, wherein altered binding of one or more protein in said sample to said antibody as compared to binding of said antibody to said wild-type protein is an indication of the presence of one or more conformer of said wild-type protein in said sample.    
     
     
         18 - 55 . (canceled)  
     
     
         56 . The method according to  claim 17 , wherein said antibody has a higher affinity for said conformer than for said wild-type protein  
     
     
         57 . The method according to  claim 17 , wherein said antibody is a monoclonal antibody.

Join the waitlist — get patent alerts

Track US2007238195A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.